Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain

NCT06692621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-03-24

No results posted yet for this study

Summary

The aim of this observational study is to compare postoperative analgesic consumption in patients who received peroperative carbetocin or oxytocin. The main question it aims to answer is:

. Does peroperative carbetocin use reduce postoperative analgesic consumption compared to oxytocin?

Patients who receive routine uterotonic agents in caesarean section surgeries will be divided into two groups and their postoperative 24-hour analgesic consumption will be compared.

Conditions

  • PREG1

Interventions

DRUG

Oxytocin

Medicines were administered in appropriate doses

DRUG

Carbetocin

Medicines were administered in appropriate doses

Sponsors & Collaborators

  • Ankara City Hospital Bilkent

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-04
Primary Completion
2025-01-07
Completion
2025-01-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06692621 on ClinicalTrials.gov